Log In
Print
BCIQ
Print
Print this Print this
 

Bladder Cancer Assay (CertNDx)

  Manage Alerts
Collapse Summary General Information
Company Predictive Biosciences Inc.
DescriptionNon-invasive diagnostic urine test combining MMP2, FGFR3, twist homolog 1 (TWIST1) and nidogen-2 (NID2) biomarkers
Molecular Target Matrix metalloproteinase 2 (MMP2) ; Fibroblast growth factor (FGF) receptor 3 (FGFR3) (CD333)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose bladder cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today